Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


04.12.2017

11 Am J Hematol
4 Ann Hematol
2 Biochem Biophys Res Commun
5 Blood
4 Br J Haematol
1 Cell
1 Exp Hematol
1 Gene
5 Int J Hematol
5 J Pediatr Hematol Oncol
1 Leuk Lymphoma
4 Leuk Res
1 Leukemia
1 PLoS Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. CHAPIRO E, Lesty C, Gabillaud C, Durot E, et al
    "Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.
    Am J Hematol. 2017 Dec 1. doi: 10.1002/ajh.24990.
    PubMed     Text format     Abstract available

  2. JAIN P, Nagarajan P, Prayag P, Benton CB, et al
    Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML.
    Am J Hematol. 2017;92:119-120.
    PubMed     Text format    

  3. PEMMARAJU N, Jain P, Medeiros LJ, Jorgenson JL, et al
    PET-positive lymphadenopathy in CLL-Not always Richter transformation.
    Am J Hematol. 2017;92:405-406.
    PubMed     Text format    

  4. JAIN P, Kantarjian H, Jabbour E, Kanagal-Shamanna R, et al
    Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML).
    Am J Hematol. 2017;92:E3-E4.
    PubMed     Text format    

  5. YU Y, Zhang T, Wang Q, Wu D, et al
    Counting bone marrow blasts as a percentage of nonerythroid cells improves the prognostic evaluation of MDS with erythroid predominance.
    Am J Hematol. 2017;92:E55-E57.
    PubMed     Text format    

  6. JAIN P, Kantarjian H, Jain N, Short NJ, et al
    Clinical characteristics and outcomes of previously untreated patients with adult onset T-ALL and T-lymphoblastic lymphoma (T-LL) with Hyper-CVAD based regimens.
    Am J Hematol. 2017 Jun 24. doi: 10.1002/ajh.24833.
    PubMed     Text format    

  7. JAIN P, Burger JA, Khoury JD
    CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferation.
    Am J Hematol. 2017;92:1113-1114.
    PubMed     Text format    

  8. MOLOGNI L, Piazza R, Khandelwal P, Pirola A, et al
    Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase chronic myeloid leukemia (CML) patients.
    Am J Hematol. 2017;92:E623-E625.
    PubMed     Text format    

  9. KOBAYASHI T, Nannya Y, Ichikawa M, Oritani K, et al
    A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).
    Am J Hematol. 2017;92:1324-1332.
    PubMed     Text format     Abstract available

  10. MOLICA M, Canichella M, Alunni Fegatelli D, Colafigli G, et al
    The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials.
    Am J Hematol. 2017;92:E661-E664.
    PubMed     Text format    

  11. JABBOUR E, Dull J, Yilmaz M, Khoury JD, et al
    Outcome of Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia after Blinatumomab Failure: No Change in the Level of CD19 Expression.
    Am J Hematol. 2017 Nov 27. doi: 10.1002/ajh.24987.
    PubMed     Text format     Abstract available


    Ann Hematol

  12. HAMADOU WS, Mani R, Besbes S, Bourdon V, et al
    GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
    Ann Hematol. 2017;96:1635-1639.
    PubMed     Text format     Abstract available

  13. HANSSON L, Asklid A, Diels J, Eketorp-Sylvan S, et al
    Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.
    Ann Hematol. 2017;96:1681-1691.
    PubMed     Text format     Abstract available

  14. SAMADI O, Breunis H, Sandoval J, Akilan K, et al
    Return to work and work-related disability among AML survivors.
    Ann Hematol. 2017;96:1625-1633.
    PubMed     Text format     Abstract available

  15. HILMI M, Bally C, Burns R, Lorillon G, et al
    Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
    Ann Hematol. 2017 Nov 23. pii: 10.1007/s00277-017-3190.
    PubMed     Text format    


    Biochem Biophys Res Commun

  16. LI M, Yao J, Zhang X, Chen X, et al
    Q482H mutation of procaspase-8 in acute myeloid leukemia abolishes caspase-8-mediated apoptosis by impairing procaspase-8 dimerization.
    Biochem Biophys Res Commun. 2017 Nov 27. pii: S0006-291X(17)32346.
    PubMed     Text format     Abstract available

  17. TIAN L, Cao J, Ji Q, Zhang C, et al
    The downregulation of miR-3173 in B-cell acute lymphoblastic leukaemia promotes cell invasion via PTK2.
    Biochem Biophys Res Commun. 2017;494.
    PubMed     Text format     Abstract available


    Blood

  18. NAGEL I, Bartels M, Duell J, Oberg HH, et al
    Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as potential mechanism of resistance to blinatumomab therapy.
    Blood. 2017 Aug 21. pii: blood-2017-05-782888. doi: 10.1182/blood-2017-05-782888
    PubMed     Text format     Abstract available

  19. ISSA GC, Kantarjian HM, Gonzalez GN, Borthakur G, et al
    Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.
    Blood. 2017;130:2084-2091.
    PubMed     Text format     Abstract available

  20. TAWARA I, Kageyama S, Miyahara Y, Fujiwara H, et al
    Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.
    Blood. 2017;130:1985-1994.
    PubMed     Text format     Abstract available

  21. JOHNSRUD AJ, Pina-Oviedo S
    Carcinocythemia (carcinoma cell leukemia).
    Blood. 2017;130:2357.
    PubMed     Text format    

  22. STRAUBE J, Ling VY, Hill GR, Lane SW, et al
    The impact of age, NPM1(mut) and FLT3(ITD) allelic ratio in patients with acute myeloid leukemia.
    Blood. 2017 Nov 28. pii: blood-2017-09-807438. doi: 10.1182/blood-2017-09-807438
    PubMed     Text format    


    Br J Haematol

  23. MEDINGER M, Passweg JR
    Acute myeloid leukaemia genomics.
    Br J Haematol. 2017;179:530-542.
    PubMed     Text format     Abstract available

  24. DONADIEU J, Beaupain B, Fenneteau O, Bellanne-Chantelot C, et al
    Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history.
    Br J Haematol. 2017;179:557-574.
    PubMed     Text format     Abstract available

  25. IGWE IJ, Yang D, Merchant A, Merin N, et al
    The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis.
    Br J Haematol. 2017;179:618-626.
    PubMed     Text format     Abstract available

  26. CHEN Y, Cheng Y, Suo P, Yan C, et al
    Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantati
    Br J Haematol. 2017;179:598-605.
    PubMed     Text format     Abstract available


    Cell

  27. YU W, Goncalves KA, Li S, Kishikawa H, et al
    Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin.
    Cell. 2017;171:849-864.
    PubMed     Text format     Abstract available


    Exp Hematol

  28. CULL AH, Snetsinger B, Buckstein R, Wells RA, et al
    Tet2 restrains inflammatory gene expression in macrophages.
    Exp Hematol. 2017;55:56-70.
    PubMed     Text format     Abstract available


    Gene

  29. MUIWO P, Pandey P, Ahmad HM, Ramachandran SS, et al
    IsomiR processing during differentiation of myelogenous leukemic cell line K562 by phorbol ester PMA.
    Gene. 2018;641:172-179.
    PubMed     Text format     Abstract available


    Int J Hematol

  30. UEMURA S, Nishimura N, Hasegawa D, Shono A, et al
    ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.
    Int J Hematol. 2017 Nov 24. pii: 10.1007/s12185-017-2371.
    PubMed     Text format     Abstract available

  31. YAMAMOTO M, Hori T, Igarashi K, Iesato K, et al
    Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Int J Hematol. 2017 Nov 27. pii: 10.1007/s12185-017-2377.
    PubMed     Text format    

  32. FUJIWARA SI, Shirato Y, Ikeda T, Kawaguchi SI, et al
    Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia.
    Int J Hematol. 2017 Nov 28. pii: 10.1007/s12185-017-2378.
    PubMed     Text format     Abstract available

  33. KIKUCHI J, Kuroda Y, Koyama D, Furukawa Y, et al
    Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells.
    Int J Hematol. 2017 Nov 28. pii: 10.1007/s12185-017-2376.
    PubMed     Text format    

  34. FUJIMAKI K, Hattori Y, Nakajima H
    10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.
    Int J Hematol. 2017 Nov 29. pii: 10.1007/s12185-017-2382.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  35. FELIX A, Leblanc T, Petit A, Nelkem B, et al
    Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000001034.
    PubMed     Text format     Abstract available

  36. BAKK I, Koch T, Stanek J, O'Brien SH, et al
    Steroid-induced Hypertension During Induction Chemotherapy for Acute Lymphoblastic Leukemia in US Children's Hospitals.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000000997.
    PubMed     Text format     Abstract available

  37. CANNATA E, Samperi P, Cimino C, Marino S, et al
    Successful Treatment of a Very Late Isolated Relapse in an Adolescent With a PICALM-MLLT10 Positive T-lineage Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000000996.
    PubMed     Text format     Abstract available


  38. Drug Rash, Eosinophilia, Systemic Symptoms (DRESS) in a Child With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000001031.
    PubMed     Text format    

  39. DAS A, Oberoi S, Trehan A, Chakrabarti A, et al
    Invasive Fungal Disease in Pediatric Acute Leukemia in the Nontransplant Setting: 8 Years' Experience From a Tertiary Care Center in North India.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000001027.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  40. RUGGIU M, Oberkampf F, Ghez D, Cony-Makhoul P, et al
    Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia.
    Leuk Lymphoma. 2017 Nov 28:1-7. doi: 10.1080/10428194.2017.1397666.
    PubMed     Text format     Abstract available


    Leuk Res

  41. PANDO A, Reagan JL, Quesenberry P, Fast LD, et al
    Extracellular vesicles in leukemia.
    Leuk Res. 2017;64:52-60.
    PubMed     Text format     Abstract available

  42. SWORDS RT, Azzam D, Al-Ali H, Lohse I, et al
    Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study.
    Leuk Res. 2017;64:34-41.
    PubMed     Text format     Abstract available

  43. TAN M, Rong Y, Su Q, Chen Y, et al
    Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells.
    Leuk Res. 2017;62:98-103.
    PubMed     Text format     Abstract available

  44. SINGH M, Bhatia P, Khera S, Trehan A, et al
    Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemia.
    Leuk Res. 2017;62:17-22.
    PubMed     Text format     Abstract available


    Leukemia

  45. LABBATE A, Tolomeo D, Cifola I, Severgnini M, et al
    MYC-containing amplicons in acute myeloid leukemia: Genomic structures, evolution, and transcriptional consequences.
    Leukemia. 2017 Nov 28. pii: leu2017337. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    PLoS Med

  46. CUMMINS NW, Rizza S, Litzow MR, Hua S, et al
    Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    PLoS Med. 2017;14:e1002461.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: